Analysts Maintain Confidence in IBM’s Strategic Direction

Despite recent pressure on technology stocks, research firm Evercore ISI has reaffirmed its bullish stance on International Business Machines Corp. (IBM). The broader sector has faced selling pressure, partly driven by renewed investor skepticism surrounding lofty artificial intelligence valuations. In this climate, Evercore not only maintains its positive outlook but suggests the company’s own financial targets for 2026 may be set too low.

Cash Flow Projections Seen as Conservative

IBM shares declined approximately 1.4% on Tuesday, mirroring a wider downturn across the tech landscape. However, Evercore analyst Amit Daryanani reiterated his “Buy” recommendation and a $345 price target in a client note.

The core of this optimism centers on free cash flow generation. IBM’s management has provided a forward-looking free cash flow projection of $15.7 billion for 2026. Evercore’s analysis posits this guidance is cautious. The firm identifies expected net income growth and the compounding effect of increasing high-margin software revenue as key drivers that could push results higher.

Even when accounting for potential headwinds like elevated capital expenditures (Capex) and rising cash taxes, Evercore believes the strength in IBM’s software and hybrid cloud segments provides sufficient momentum for cash generation to exceed current market expectations.

Key Takeaways
* Evercore ISI reaffirms a “Buy” rating with a $345 price target.
* The 2026 free cash flow target of $15.7 billion is viewed as potentially conservative.
* Shares fell roughly 1.4% Tuesday amid broader “AI jitters” in the market.

Should investors sell immediately? Or is it worth buying IBM?

Strategic Acquisition of Confluent Advances

Beyond cash flow, the market is closely watching IBM’s execution of its strategic vision. The company is nearing the completion of its $11 billion acquisition of data-streaming platform Confluent. A regulatory filing last week confirmed that Confluent shareholders have approved the merger agreement, clearing a significant hurdle for the deal.

IBM has linked this acquisition to strengthening its position in the hybrid cloud and real-time data analytics arena. The strategic rationale involves integrating Confluent’s capabilities to enhance IBM’s infrastructure offerings, aiming to provide enterprise clients with superior tools for managing data streams across diverse cloud environments.

Upcoming Catalyst: Technology Summit on February 26

Attention now turns to a near-term event that could provide fresh insights. IBM has scheduled a Technology Summit for February 26. The company is expected to unveil further details regarding its “agentic AI” strategy, with a likely focus on the watsonx portfolio and the deployment of autonomous AI agents within business workflows.

This event holds particular significance as investors are currently keen for tangible evidence of how AI investments translate into monetization. The summit will therefore offer a clear and timely update on IBM’s progress, irrespective of whether the stock faces continued short-term pressure from sector-wide trends.